Recent Posts
- Study identifies how tamoxifen stimulates uterine cell growth and cancer
- Natural Compound Stops Diabetic Retinopathy
- HIV vaccine moves to human testing if FDA approval is granted
- New targeted therapy finds and eliminates deadly leukemia stem cells
- Interferon alpha can delay full onset of type I diabetes
- Emerging techniques put a new twist on ankle repair
- Will IVF work for a particular patient? The answer may be found in her blood
- Mayo Clinic study finds celiac disease 4 times more common than in 1950s
Study identifies how tamoxifen stimulates uterine cell growth and cancer
UCSF researchers have identified a new “feed-forward” pathway linking estrogen receptors in the membrane of the uterus to a process that increases local estrogen levels and promotes cell growth.
The research is significant in helping determine why tamoxifen and other synthetic estrogens are linked to increased rates of endometriosis and uterine cancer, and identifies a pathway that could be targeted in drug therapies for those diseases, researchers say.
Natural Compound Stops Diabetic Retinopathy
Researchers at the University of Oklahoma Health Sciences Center have found a way to use a natural compound to stop one of the leading causes of blindness in the United States. The research appears online this month in the journal Diabetes, a publication of the American Diabetes Association.
HIV vaccine moves to human testing if FDA approval is granted
An HIV/AIDS vaccine called SAV001H, developed in Canada has passed safety tests in animals with the next step to begin human trials in the U.S. Trials of the new vaccine on animals have reportedly resulted in good anti-body reactions with no adverse effects. The vaccine was created by Dr. Chil-Yong Kang and his team at The Canadian University of Western Ontario partneted with Sumagen Canada, a subsidiary of the Korean pharmaceutical company.
Read the story
New targeted therapy finds and eliminates deadly leukemia stem cells
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer. The study, published by Cell Press in the July 2nd issue of the journal Cell Stem Cell, describes exciting preclinical studies in which a new therapeutic approach selectively attacks human cancer cells grown in the lab and in animal models of leukemia.
Interferon alpha can delay full onset of type I diabetes
A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston.
Emerging techniques put a new twist on ankle repair
Using cells grown in a lab, new treatments eliminate risks of traditional procedures
People with ankle injuries who do not respond successfully to initial treatment may have a second chance at recovery, thanks to two new procedures developed to restore the injured area, according to a study published in the July 2009 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).
Cancer Treatment
Study identifies how tamoxifen stimulates uterine cell growth and cancerUCSF researchers have identified a new “feed-forward” pathway linking estrogen receptors in the membrane of the uterus...
Near miracle outcomes in prostate cancer studyTwo Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental...
Discovery of the cell’s water gate may lead to new cancer drugsThe flow of water into and out from the cell may play a crucial role in several types of cancer. Scientists at the University of Gothenburg...
Less invasive CT-scan based colorectal cancer screening method shows good accuracyComputed tomographic (CT) colonography may offer patients at increased risk of colorectal cancer an alternative to colonoscopy that...
Stem Cell Research
New targeted therapy finds and eliminates deadly leukemia stem cellsNew research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously...
Stem cells from fat tissue offer hope for MS treatmentA preliminary study on the use of stem cells obtained from a patient’s own adipose tissue in the treatment of multiple sclerosis...
Stem cells demonstrated to reverse macular degeneration blindnessscientists have developed the worlds first stem cell therapy to cure the most common cause of blindness. Surgeons predict it will become...
Scientists discover technique to jumpstart bone’s healing processIn-body stem cell therapy has enormous potential for bone injuries Rarely will physicians use the word “miraculous” when...
Diabetes
Natural Compound Stops Diabetic RetinopathyResearchers at the University of Oklahoma Health Sciences Center have found a way to use a natural compound to stop one of the leading...
Interferon alpha can delay full onset of type I diabetesA low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes,...
Potential preventative therapy for Type 1 diabetesPotential preventative therapy for Type 1 diabetesScientists believe they may have found a preventative therapy for Type 1 diabetes,...
Stem cell transplantation enables patients with diabetes become insulin freeThe majority of patients with type 1 diabetes who underwent a certain type of stem cell transplantation became insulin free, several...
Heart Disease
New way to fix leaking mitral heart valves safe in initial testingStudy highlights: A novel method to seal leaking heart valves was proven safe in its first use in heart failure patients. If effective...
Blocking a muscle growth-limiting hormone protects against obesity and atherosclerosisKnockout of myostatin, a growth factor that limits muscle growth, can decrease body fat and promote resistance against developing atherosclerosis,...
New device detects heart disease using less than one drop of bloodNew tool described in the FASEB Journal may help physicians monitor heart disease and help scientists grow new vascular tissue for...
Bone marrow cell therapy may be beneficial for patients with ischemic heart diseaseThe injection of bone marrow cells into the heart of patients with chronic myocardial ischemia (reduced blood flow to some areas of...



